Eur Respir J 1993; 6: 1282-1286
Copyright © ERS Journals Ltd 1993
Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?
SP Matusiewicz,
IJ Williamson,
PJ Sime,
PH Brown,
PR Wenham,
GK Crompton,
and
AP Greening
Total plasma lactate dehydrogenase (LDH) activity may be elevated in cryptogenic fibrosing alveolitis (CFA) and extrinsic allergic alveolitis (EAA), and may be a useful monitor of disease progress. In a retrospective, primary referral centre study, we compared LDH at presentation, prior to bronchoalveolar lavage BAL, and after treatment and follow-up with changes in pulmonary function, in patients with CFA, EAA and pulmonary sarcoidosis. Plasma levels of LDH at presentation in CFA (n = 47) and EAA (n = 10) were significantly higher than in patients with sarcoidosis (n = 36). LDH activity decreased in patients with improving lung function (EAA, p = 0.008; CFA, p = 0.02), whereas it increased in CFA patients with deteriorating lung function (p = 0.015). Total plasma LDH is a simple, though nonspecific test, which appears to reflect changes of disease activity in patients with CFA and EAA.
This article has been cited by other articles:

|
 |

|
 |
 
A. Turna, O. Solak, E. Cetinkaya, A. Kilicgun, M. Metin, A. Sayar, and A. Gurses
Lactate dehydrodgenase levels predict pulmonary morbidity after lung resection for non-small cell lung cancer
Eur. J. Cardiothorac. Surg.,
September 1, 2004;
26(3):
483 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Karan, D. L. Kelly, A. Rizzino, M.-F. Lin, and S. K. Batra
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
Carcinogenesis,
June 1, 2002;
23(6):
967 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Tsukamoto, H Hayakawa, A Sato, K Chida, H Nakamura, and K Miura
Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis
Thorax,
November 1, 2000;
55(11):
958 - 961.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. TAKAHASHI, Y. KUROKI, H. TANAKA, T. SAITO, K. KUROKAWA, H. CHIBA, A. SAGAWA, H. NAGAE, and S. ABE
Serum Levels of Surfactant Proteins A and D Are Useful Biomarkers for Interstitial Lung Disease in Patients with Progressive Systemic Sclerosis
Am. J. Respir. Crit. Care Med.,
July 1, 2000;
162(1):
258 - 263.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S P Matusiewicz, W A H Wallace, and G K Crompton
Hypersensitivity pneumonitis associated with co-proxamol (paracetamol + dextropropoxyphene) therapy
Postgrad. Med. J.,
August 1, 1999;
75(886):
475 - 477.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. W. ZIEGENHAGEN, P. ZABEL, G. ZISSEL, M. SCHLAAK, and J. MULLER-QUERNHEIM
Serum Level of Interleukin 8 Is Elevated in Idiopathic Pulmonary Fibrosis and Indicates Disease Activity
Am. J. Respir. Crit. Care Med.,
March 1, 1998;
157(3):
762 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1993 by the European Respiratory Society.
|